Chlorphenesin carbamate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for chlorphenesin carbamate and what is the scope of freedom to operate?
Chlorphenesin carbamate
is the generic ingredient in one branded drug marketed by Pamlab Llc and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for chlorphenesin carbamate.
Summary for chlorphenesin carbamate
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 49 |
Clinical Trials: | 1 |
Patent Applications: | 1,146 |
DailyMed Link: | chlorphenesin carbamate at DailyMed |
Recent Clinical Trials for chlorphenesin carbamate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
ONCOCROSS Co., Ltd. | Phase 1 |
CytoGen, Inc. | Phase 1 |
Changhoon Yoo | Phase 1 |
Medical Subject Heading (MeSH) Categories for chlorphenesin carbamate
Anatomical Therapeutic Chemical (ATC) Classes for chlorphenesin carbamate
US Patents and Regulatory Information for chlorphenesin carbamate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pamlab Llc | MAOLATE | chlorphenesin carbamate | TABLET;ORAL | 014217-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |